Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1989 6
1991 1
1992 1
1994 2
1995 4
1996 11
1997 4
1998 6
1999 4
2000 8
2001 5
2002 8
2003 4
2004 6
2005 4
2006 6
2007 4
2008 5
2009 8
2010 8
2011 12
2012 5
2013 13
2014 18
2015 16
2016 14
2017 19
2018 12
2019 11
2020 20
2021 16
2022 20
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Cancer-Related Fatigue, Version 2.2015.
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C; National comprehensive cancer network. Berger AM, et al. Among authors: breitbart ws. J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39. doi: 10.6004/jnccn.2015.0122. J Natl Compr Canc Netw. 2015. PMID: 26285247 Free PMC article.
Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual funct …
Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness o …
Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis.
McFarland DC, Doherty M, Atkinson TM, O'Hanlon R, Breitbart W, Nelson CJ, Miller AH. McFarland DC, et al. Among authors: breitbart w. Cancer. 2022 Jul 1;128(13):2504-2519. doi: 10.1002/cncr.34193. Epub 2022 Apr 13. Cancer. 2022. PMID: 35417925
BACKGROUND: Depressive symptoms in patients with cancer are associated with poor quality of life and decreased survival. Although inflammation is reliably associated with depression in otherwise healthy individuals, the association in patients with cancer remains un …
BACKGROUND: Depressive symptoms in patients with cancer are associated with poor quality of life and decreased survival. Although inf …
Tumor Mutation Burden and Depression in Lung Cancer: Association With Inflammation.
McFarland DC, Jutagir DR, Miller AH, Breitbart W, Nelson C, Rosenfeld B. McFarland DC, et al. Among authors: breitbart w. J Natl Compr Canc Netw. 2020 Apr;18(4):434-442. doi: 10.6004/jnccn.2019.7374. J Natl Compr Canc Netw. 2020. PMID: 32259781 Free PMC article.
BACKGROUND: Patients with lung cancer with greater systemic inflammation have higher rates of depression. ...TMB was measured using the Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets. ...
BACKGROUND: Patients with lung cancer with greater systemic inflammation have higher rates of depression. ...TMB was measured using t …
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.
Hui D, De La Rosa A, Wilson A, Nguyen T, Wu J, Delgado-Guay M, Azhar A, Arthur J, Epner D, Haider A, De La Cruz M, Heung Y, Tanco K, Dalal S, Reddy A, Williams J, Amin S, Armstrong TS, Breitbart W, Bruera E. Hui D, et al. Among authors: breitbart w. Lancet Oncol. 2020 Jul;21(7):989-998. doi: 10.1016/S1470-2045(20)30307-7. Epub 2020 May 29. Lancet Oncol. 2020. PMID: 32479786 Free PMC article. Clinical Trial.
We assessed the effect of three neuroleptic strategies on refractory agitation in patients with cancer with terminal delirium. METHODS: In this single-centre, double-blind, parallel-group, randomised trial, patients with advanced cancer, aged at least 18 years, admi …
We assessed the effect of three neuroleptic strategies on refractory agitation in patients with cancer with terminal delirium. METHOD …
Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial.
Chochinov HM, Kristjanson LJ, Breitbart W, McClement S, Hack TF, Hassard T, Harlos M. Chochinov HM, et al. Among authors: breitbart w. Lancet Oncol. 2011 Aug;12(8):753-62. doi: 10.1016/S1470-2045(11)70153-X. Epub 2011 Jul 6. Lancet Oncol. 2011. PMID: 21741309 Free PMC article. Clinical Trial.
INTERPRETATION: Although the ability of dignity therapy to mitigate outright distress, such as depression, desire for death or suicidality, has yet to be proven, its benefits in terms of self-reported end-of-life experiences support its clinical application for patients nearing d …
INTERPRETATION: Although the ability of dignity therapy to mitigate outright distress, such as depression, desire for death or suicidality, …
Psycho-oncology.
Breitbart WS, Alici Y. Breitbart WS, et al. Harv Rev Psychiatry. 2009;17(6):361-76. doi: 10.3109/10673220903465700. Harv Rev Psychiatry. 2009. PMID: 19968451 Review.
The psychosocial and psychiatric sequelae of cancer are highly prevalent, diverse, and challenging for clinicians to manage. ...This review presents an overview of the history of psycho-oncology, common psychological responses to cancer, factors in adapting to ca …
The psychosocial and psychiatric sequelae of cancer are highly prevalent, diverse, and challenging for clinicians to manage. ...This …
Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: A randomized controlled trial in patients with advanced cancer.
Breitbart W, Pessin H, Rosenfeld B, Applebaum AJ, Lichtenthal WG, Li Y, Saracino RM, Marziliano AM, Masterson M, Tobias K, Fenn N. Breitbart W, et al. Cancer. 2018 Aug 1;124(15):3231-3239. doi: 10.1002/cncr.31539. Epub 2018 May 14. Cancer. 2018. PMID: 29757459 Free PMC article. Clinical Trial.
BACKGROUND: Patients with advanced cancer have high rates of psychological distress, including depression, anxiety, and spiritual despair. ...Thus, the benefits of meaning-centered psychotherapy appear to be unique to the intervention and highlight the importance of addres …
BACKGROUND: Patients with advanced cancer have high rates of psychological distress, including depression, anxiety, and spiritual des …
Forgiveness.
Breitbart W. Breitbart W. Palliat Support Care. 2018 Jun;16(3):244-245. doi: 10.1017/S1478951518000408. Palliat Support Care. 2018. PMID: 29877784 Free PMC article. No abstract available.
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
Hui D, Frisbee-Hume S, Wilson A, Dibaj SS, Nguyen T, De La Cruz M, Walker P, Zhukovsky DS, Delgado-Guay M, Vidal M, Epner D, Reddy A, Tanco K, Williams J, Hall S, Liu D, Hess K, Amin S, Breitbart W, Bruera E. Hui D, et al. Among authors: breitbart w. JAMA. 2017 Sep 19;318(11):1047-1056. doi: 10.1001/jama.2017.11468. JAMA. 2017. PMID: 28975307 Free PMC article. Clinical Trial.
OBJECTIVE: To compare the effect of lorazepam vs placebo as an adjuvant to haloperidol for persistent agitation in patients with delirium in the setting of advanced cancer. DESIGN, SETTING, AND PARTICIPANTS: Single-center, double-blind, parallel-group, randomized clinical …
OBJECTIVE: To compare the effect of lorazepam vs placebo as an adjuvant to haloperidol for persistent agitation in patients with delirium in …
251 results